Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-679-5 | CAS number: 68-12-2
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
- Dose descriptor starting point:
- NOAEC
- Value:
- 6.2 mg/m³
- Explanation for the modification of the dose descriptor starting point:
RAC is of the opinion (ECHA/RAC/RES-O-0000006695-63-01/F) that a human NOAEC can be set based on the NOAEC of 6.2 mg/m³ reported in the Kilo et al. study (2016) for hepatic effects in humans, resulting in a DNEL of 6 mg/m³. RAC further notes that DMF is a well-known reproductive toxicant and thus supports the inhalation DNEL for developmental toxicity in rabbits calculated to 6 mg/m³ in the restriction proposal, based on a NOAEC of 150 mg/m³ for malformations in a rabbit developmental toxicity study (Hellwiget al., 1991; Key_BASFAG1989.Developmental toxicity / teratogenicity).
Overall, RAC proposes a systemic long term DNEL of 6 mg/m³ for the inhalation route based on a combination of human data and rabbit developmental toxicity data.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.1 mg/kg bw/day
- Most sensitive endpoint:
- developmental toxicity / teratogenicity
- Route of original study:
- Dermal
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 90
- Dose descriptor starting point:
- LOAEL
- Value:
- 100 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
RAC decided in its opinion (ECHA/RAC/RES-O-0000006695-63-01/F) to use the LOAEL from the dermal developmental toxicity study (i.e. 100 mg/kg/day) (Key_BASFAG1984.Developmental toxicity / teratogenicity) as dose-descriptor starting point.
- AF for dose response relationship:
- 3
- Justification:
- default (LOAEL)
- AF for interspecies differences (allometric scaling):
- 2.4
- Justification:
- default for rabbit
- AF for other interspecies differences:
- 2.5
- Justification:
- default
- AF for intraspecies differences:
- 5
- Justification:
- default for workers
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.1 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 2
- Dose descriptor starting point:
- NOAEC
- Value:
- 6.2 mg/m³
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 2.2 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Although no consumer uses are relevant the inhalation systemic long-term DNEL for the general population is derived for the assessment of man via environment.
RAC is of the opinion (ECHA/RAC/RES-O-0000006695-63-01/F) that a human NOAEC can be set based on the NOAEC of 6.2 mg/m³ reported in the Kilo et al. study (2016) for hepatic effects in humans. As this NOAEC was obtained for workers, it needs to be modified for the general population by correction for exposure duration (5 d/week vs. 7 d/week and 8 h/d vs. 24 h/d) and for increased respiratory volume of workers under light activity (10m³/8h / 6.7 m³/8h = 1.5).
Modified dose descriptor starting point: 6.2 mg/m³ x 5 d/7 d x 8 h/24 h x 1.5 = 2.2 mg/m³
- AF for intraspecies differences:
- 2
- Justification:
- as the dose descriptor starting point was derived from an epidemiological study in a mixed group of workers, an AF of 2 is needed to account for more sensitive sub-groups in the general population
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.16 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 2
- Dose descriptor starting point:
- other: NOAEC of 6.2 mg/m³
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 0.31 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Although no consumer uses are relevant the oral systemic long-term DNEL for the general population is derived for the assessment of man via environment.
RAC is of the opinion (ECHA/RAC/RES-O-0000006695-63-01/F) that a human NOAEC can be set based on the NOAEC of 6.2 mg/m³ reported in the Kilo et al. study (2016) for hepatic effects in humans. This NOAEC was obtained for workers. It needs to be modified for the general population by correction for exposure duration (5 d/week vs. 7 d/week and 8 h/d vs. 24 h/d) and for the increased respiratory volume of workers under light activity (10 m³/8h / 6.7 m³/8h = 1.5).
In addition it is extrapolated from the inhalation to the oral route by using the sRV for workers for 8 h of 10 m³/person (10 m³ / 70 kg = 0.14 m³ / kg bw)
Modified dose descriptor starting point:
6.2 mg/m³ x 0.14 m³/kg bw/8 h = 0.868 mg/kg bw/8 h
0.868 mg/kg bw/8 h x 5 d/7 d x 8 h/24 h x 1.5 = 0.31 mg/kg bw/d
- AF for intraspecies differences:
- 2
- Justification:
- as the dose descriptor starting point was derived from an epidemiological study in a mixed group of workers, an AF of 2 is needed to account for more sensitive sub-groups in the general population
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
